title: Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge.
abstract: Development of asthma after exposure to toluene diisocyanate (TDI) has been recognized in a variety of occupational settings. However, the pathogenesis of isocyanate-induced asthma remains controversial. In particular, the role of IgE in the development of TDI-induced asthma has remained uncertain. To investigate predictive factors for response to inhalation challenge with TDI, we analyzed data from 63 subjects referred for evaluation of respiratory symptoms thought to be related to TDI sensitization. All subjects underwent interview, routine phlebotomy, spirometry, methacholine challenge, and allergy skin testing prior to TDI challenge. Spirometry and methacholine challenge were repeated 1 day after TDI challenge. The cumulative dose of methacholine needed to produce a 20% decrease in FEV1 (PD20) was determined. A PD20 of 1.4 mg or more was considered normal. Subjects were challenged by exposure to 5 to 10 ppb TDI for up to 30 min in a 9 m3 exposure chamber. A positive response was a 20% or more decrease in FEV1 within 1 h (early) or beyond 1 h (late) after TDI exposure. Thirty-four subjects (54%) had a positive response, of whom 12 (35% of responders) had isolated early responses, 13 (38%) had isolated late responses, and the remainder had dual responses. Thirty-two individuals (51%) had a positive response to methacholine (AR+) prior to TDI challenge. AR+ was strongly associated with a positive TDI challenge: 23 AR+ subjects (72%) had a positive TDI challenge, compared with only 11 AR- subjects (35%) (p < 0.01). AR positivity did not predict the time of onset of TDI response.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pennsylvania.
authors.forename: M H
authors.initials: MH
authors.lastname: Karol
authors.forename: D J
authors.initials: DJ
authors.lastname: Tollerud
authors.forename: T P
authors.initials: TP
authors.lastname: Campbell
authors.forename: L
authors.initials: L
authors.lastname: Fabbri
authors.forename: P
authors.initials: P
authors.lastname: Maestrelli
authors.forename: M
authors.initials: M
authors.lastname: Saetta
authors.forename: C E
authors.initials: CE
authors.lastname: Mapp
mesh_terms: D000328:Adult; D001249:Asthma / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis* / Q000276:immunology; D016535:Bronchial Hyperreactivity / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis* / Q000276:immunology; D001985:Bronchial Provocation Tests; D016009:Chi-Square Distribution; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood*; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D016210:Methacholine Chloride; D009784:Occupational Diseases / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis* / Q000276:immunology; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D012882:Skin Tests; D014051:Toluene 2,4-Diisocyanate / Q000009:adverse effects*
chemical_list: D007074:Immunoglobulin G; D016210:Methacholine Chloride; D014051:Toluene 2,4-Diisocyanate; D007073:Immunoglobulin E